ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

117
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
Refresh
14 Jul 2024 07:00

Last Week in Event SPACE: Toyota, Asia Cement, Hanwha Corp, Kokusai Electric, Keisei Electric

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
414 Views
Share
bullishAltium Ltd
13 Jul 2024 15:00

(Mostly) Asia-Pac M&A: Second Chance Properties, Shinsung Tongsang, Rex Minerals, Canvest, Altium

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
437 Views
Share
08 Jul 2024 00:36

Merger Arb Mondays (08 Jul) - China TCM, L'Occitane, A8 Media, GA Pack, Asia Cement, Hollysys, MMA

This week, the highest gross spreads are HEC Pharma (131.3%), China TCM (26.0%), A8 New Media (12.5%), GA Pack (11.8%), Asia Cement China (11.0%),...

Logo
386 Views
Share
bullishL'Occitane
06 Jul 2024 15:00

(Mostly) Asia-Pac M&A: Sermsuk, L'Occitane, Shinko Electric, MMA Offshore, Hollysys

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
447 Views
Share
bullishFancl Corp
01 Jul 2024 07:00

(Mostly) Asia M&A, June 2024: Fancl, Capitol Health, Infocom,Jeisys Medical, Nagatanien, Henlius Bio

For the month of June, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$6bn. The average premium for the new deals...

Logo
384 Views
Share
x